Case Report Links MS Therapy Daclizumab to Pulmonary Sarcoidosis
A recent study has reported on a multiple sclerosis (MS) patient who developed pulmonary sarcoidosis after receiving the relapsing-remitting MS (RRMS) therapy daclizumab. The report “Pulmonary Sarcoidosis in a patient with Multiple Sclerosis on daclizumab monotherapy,” was published in Multiple Sclerosis and Related Disorders. Daclizumab is a…